The University of Texas MD Anderson Cancer Center and Myriad Genetics, Inc. today announced a five-year strategic alliance to accelerate the clinical evaluation and development of Myriad’s molecular residual disease (MRD) assay.
Children may have experienced “excess” doubling up during COVID-19 pandemic
Grandparents appeared to serve as an important private safety net when COVID-19 first hit the U.S., according to a study led by a Washington State
August 30, 2023